EMA recommends approval of six medicines, expands indications for nine

EMA’s human medicines committee (CHMP) published the outcomes of their meeting on Friday (30 January). EMA recommended six medicines for approval at its meeting and extended the therapeutic indications of nine medicines. Here are some highlights: Menopause: The committee recommended marketing authorisation for Fylrevy (estetrol),  a hormone replacement therapy for oestrogen deficiency symptoms in postmenopausal […]